What is the current annual cash & cash equivalents of NVS?

As of today, NVS annual cash & cash equivalents is $11.59B

What is 1-year change in NVS annual cash & cash equivalents?

NVS annual cash & cash equivalents is down -13.87% year-over-year

What is 3-year change in NVS annual cash & cash equivalents?

NVS annual cash & cash equivalents is down -38.77% over the past 3 years

How far is NVS annual cash & cash equivalents from its all-time high?

NVS annual cash & cash equivalents is currently -59.09% below its historical high of $28.33B set on December 31, 2021

How does NVS annual cash & cash equivalents rank versus sector peers?

NVS annual cash & cash equivalents is higher than 99.47% of companies in Healthcare sector

When is NVS next annual earnings release?

The next annual earnings release for NVS is on February 3, 2027

What is the current quarterly cash & cash equivalents of NVS?

As of today, NVS quarterly cash & cash equivalents is $8.98B

What is NVS quarterly cash & cash equivalents most recent change?

NVS quarterly cash & cash equivalents was up +16.71% on September 30, 2026

What is 1-year change in NVS quarterly cash & cash equivalents?

NVS quarterly cash & cash equivalents is down -7.98% year-over-year

How far is NVS quarterly cash & cash equivalents from its all-time high?

NVS quarterly cash & cash equivalents is currently -68.32% below its historical high of $28.33B set on December 31, 2021

How does NVS quarterly cash & cash equivalents rank versus sector peers?

NVS quarterly cash & cash equivalents is higher than 98.92% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on February 3, 2027

Novartis AG (NVS) Cash & Equivalents History & Chart

Annual Cash & Cash Equivalents

$11.59B$1.87B-13.87%

December 31, 2025

Summary

Current Value: As of today, NVS annual cash & cash equivalents is $11.59B, down -13.87% on December 31, 2025
Historical Performance: NVS annual cash & cash equivalents is down -38.77% over the past 3 years, up +0.23% over the past 5 years
All-Time High Comparison: NVS annual cash & cash equivalents is currently -59.09% below its historical high of $28.33B set on December 31, 2021
3-Year Low Comparison: NVS annual cash & cash equivalents is at its 3-year low
Sector Comparison: NVS annual cash & cash equivalents is higher than 99.47% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

NVS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$11.59B	-13.9%	-38.8%	+0.2%	+42.2%
Quarterly Cash & Cash Equivalents	Sep 30, 26	$8.98B	-8.0%	-29.3%	+10.0%	+61.1%
Price	Nov 6, 26	$162.55	+28.4%	+73.9%	+94.3%	+223.4%
Annual Current Assets	Dec 31, 25	$30.46B	+2.5%	-17.5%	+2.6%	+13.9%
Annual Total Liabilities	Dec 31, 25	$69.02B	+10.2%	+10.7%	-8.6%	+28.6%
Annual Working Capital	Dec 31, 25	$3.18B	+214.4%	-61.5%	+194.0%	+56.6%
Annual Net Income	Dec 31, 25	$14.04B	+17.6%	+131.6%	+72.9%	+42.0%

Cash and Cash Equivalents Highs

NVS Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$18.93B	N/A	-38.8%
5Y	$28.33B	Dec 31, 21	-59.1%
All	$28.33B	Dec 31, 21	-59.1%

Cash and Cash Equivalents Lows

NVS Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$11.59B	Dec 31, 25	at low
5Y	$11.56B	N/A	+0.2%
All	$5.08B	Dec 31, 11	+128.4%

Cash and Cash Equivalents History

Year	Value	Change
2025	$11.59B	-13.9%
2024	$13.46B	-6.7%
2023	$14.43B	-23.8%
2022	$18.93B	-33.2%
2021	$28.33B	+145.0%
2020	$11.56B	+1.0%
2019	$11.45B	-28.2%
2018	$15.95B	+68.2%
2017	$9.49B	+22.0%
2016	$7.78B	+42.8%
2015	$5.45B	-60.7%
2014	$13.86B	+50.3%
2013	$9.22B	+13.6%
2012	$8.12B	+60.0%

Year	Value	Change
2011	$5.08B	-37.7%
2010	$8.15B	-53.3%
2009	$17.45B	+185.3%
2008	$6.12B	-53.7%
2007	$13.20B	+65.9%
2006	$7.95B	-27.2%
2005	$10.93B	-21.5%
2004	$13.93B	+4.8%
2003	$13.29B	+8.6%
2002	$12.24B	-3.3%
2000	$12.66B	+24.2%
1999	$10.20B	-23.7%
1995	$13.36B	-

FAQ

What is the current annual cash & cash equivalents of NVS?: As of today, NVS annual cash & cash equivalents is $11.59B
What is 1-year change in NVS annual cash & cash equivalents?: NVS annual cash & cash equivalents is down -13.87% year-over-year
What is 3-year change in NVS annual cash & cash equivalents?: NVS annual cash & cash equivalents is down -38.77% over the past 3 years
How far is NVS annual cash & cash equivalents from its all-time high?: NVS annual cash & cash equivalents is currently -59.09% below its historical high of $28.33B set on December 31, 2021
How does NVS annual cash & cash equivalents rank versus sector peers?: NVS annual cash & cash equivalents is higher than 99.47% of companies in Healthcare sector
When is NVS next annual earnings release?: The next annual earnings release for NVS is on February 3, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$8.98B$1.28B+16.71%

September 30, 2026

Summary

Current Value: As of today, NVS quarterly cash & cash equivalents is $8.98B, up +16.71% on September 30, 2026
Historical Performance: NVS quarterly cash & cash equivalents is down -7.98% year-over-year, down -29.30% over the past 3 years
All-Time High Comparison: NVS quarterly cash & cash equivalents is currently -68.32% below its historical high of $28.33B set on December 31, 2021
3-Year Low Comparison: NVS quarterly cash & cash equivalents is +28.64% above its 3-year low of $6.98B reached on March 31, 2026
Sector Comparison: NVS quarterly cash & cash equivalents is higher than 98.92% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Sep 30, 26	$8.98B	+16.7%	-8.0%	-29.3%	+10.0%
Annual Cash & Cash Equivalents	Dec 31, 25	$11.59B	–	-13.9%	-38.8%	+0.2%
Price	Nov 6, 26	$162.55	+5.4%	+28.4%	+73.9%	+94.3%
Quarterly Current Assets	Sep 30, 26	$28.75B	+5.1%	+1.9%	-37.0%	+9.5%
Quarterly Total Liabilities	Sep 30, 26	$79.59B	-0.6%	+27.3%	+6.9%	+23.8%
Quarterly Working Capital	Sep 30, 26	-$3.78B	+14.1%	+0.6%	-38.2%	-4.2%
Quarterly Net Income	Sep 30, 26	$1.19B	-63.5%	-69.7%	-21.4%	-56.9%

Quarterly Cash & Cash Equivalents Highs

NVS Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$11.59B	Dec 31, 25	-22.6%
3Y	$14.43B	Dec 31, 23	-37.8%
5Y	$28.33B	Dec 31, 21	-68.3%
All	$28.33B	Dec 31, 21	-68.3%

Quarterly Cash & Cash Equivalents Lows

NVS Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$6.98B	Mar 31, 26	+28.6%
3Y	$6.98B	Mar 31, 26	+28.6%
5Y	$6.98B	Mar 31, 26	+28.6%
All	$2.64B	Jun 30, 01	+240.2%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Sep 2026	$8.98B	+16.7%
Jun 2026	$7.69B	+10.2%
Mar 2026	$6.98B	-39.8%
Dec 2025	$11.59B	+18.8%
Sep 2025	$9.75B	+39.3%
Jun 2025	$7.00B	-2.7%
Mar 2025	$7.20B	-46.5%
Dec 2024	$13.46B	-4.0%
Sep 2024	$14.02B	+66.2%
Jun 2024	$8.44B	-13.5%
Mar 2024	$9.75B	-32.4%
Dec 2023	$14.43B	+13.7%
Sep 2023	$12.70B	+13.6%
Jun 2023	$11.17B	-8.9%
Mar 2023	$12.26B	-35.2%
Dec 2022	$18.93B	-0.9%
Sep 2022	$19.10B	-3.3%
Jun 2022	$19.76B	+5.0%
Mar 2022	$18.81B	-33.6%
Dec 2021	$28.33B	+247.1%
Sep 2021	$8.16B	+52.4%
Jun 2021	$5.36B	+31.4%
Mar 2021	$4.08B	-64.7%
Dec 2020	$11.56B	+6.4%
Sep 2020	$10.87B	+72.7%
Jun 2020	$6.29B	+26.5%
Mar 2020	$4.97B	-56.6%
Dec 2019	$11.45B	+31.3%
Sep 2019	$8.72B	-15.7%
Jun 2019	$10.34B	+45.3%
Mar 2019	$7.11B	-55.4%
Dec 2018	$15.95B	+8.4%
Sep 2018	$14.71B	+11.9%
Jun 2018	$13.15B	+104.7%
Mar 2018	$6.42B	-32.3%
Dec 2017	$9.49B	+0.7%
Sep 2017	$9.42B	+11.7%
Jun 2017	$8.44B	+2.4%
Mar 2017	$8.24B	+5.9%
Dec 2016	$7.78B	-0.1%
Sep 2016	$7.79B	+35.6%
Jun 2016	$5.74B	+12.9%
Mar 2016	$5.09B	-6.6%
Dec 2015	$5.45B	-10.2%
Sep 2015	$6.06B	+3.2%
Jun 2015	$5.88B	-20.2%
Mar 2015	$7.36B	-46.9%
Dec 2014	$13.86B	+32.9%
Sep 2014	$10.43B	+42.2%

Month	Value	Change
Jun 2014	$7.34B	-5.0%
Mar 2014	$7.72B	-16.3%
Dec 2013	$9.22B	+25.7%
Sep 2013	$7.34B	+39.8%
Jun 2013	$5.25B	-13.0%
Mar 2013	$6.04B	-25.7%
Dec 2012	$8.12B	+40.0%
Sep 2012	$5.80B	-5.0%
Jun 2012	$6.11B	+13.3%
Mar 2012	$5.39B	+6.2%
Dec 2011	$5.08B	-8.9%
Sep 2011	$5.57B	-0.6%
Jun 2011	$5.60B	-36.1%
Mar 2011	$8.76B	+7.5%
Dec 2010	$8.15B	+2.0%
Sep 2010	$7.99B	-65.2%
Jun 2010	$23.00B	+15.6%
Mar 2010	$19.90B	+14.0%
Dec 2009	$17.45B	+23.4%
Sep 2009	$14.14B	+20.6%
Jun 2009	$11.73B	+48.4%
Mar 2009	$7.91B	+29.2%
Dec 2008	$6.12B	-23.0%
Sep 2008	$7.95B	-50.9%
Jun 2008	$16.19B	+21.2%
Mar 2008	$13.36B	+1.2%
Dec 2007	$13.20B	-9.2%
Sep 2007	$14.53B	+91.8%
Jun 2007	$7.58B	+9.6%
Mar 2007	$6.91B	-13.1%
Dec 2006	$7.95B	-6.4%
Sep 2006	$8.50B	+15.6%
Jun 2006	$7.36B	-33.5%
Mar 2006	$11.06B	+1.2%
Dec 2005	$10.93B	+36.9%
Sep 2005	$7.98B	-15.4%
Jun 2005	$9.43B	-23.4%
Mar 2005	$12.32B	-11.5%
Dec 2004	$13.93B	+21.1%
Sep 2004	$11.50B	-13.5%
Dec 2003	$13.29B	+8.6%
Dec 2002	$12.24B	+18.2%
Sep 2002	$10.36B	-19.3%
Jun 2002	$12.84B	-2.4%
Dec 2001	$13.16B	+398.7%
Jun 2001	$2.64B	-51.6%
Dec 2000	$5.45B	+59.5%
Jun 2000	$3.42B	-

FAQ

What is the current quarterly cash & cash equivalents of NVS?: As of today, NVS quarterly cash & cash equivalents is $8.98B
What is NVS quarterly cash & cash equivalents most recent change?: NVS quarterly cash & cash equivalents was up +16.71% on September 30, 2026
What is 1-year change in NVS quarterly cash & cash equivalents?: NVS quarterly cash & cash equivalents is down -7.98% year-over-year
How far is NVS quarterly cash & cash equivalents from its all-time high?: NVS quarterly cash & cash equivalents is currently -68.32% below its historical high of $28.33B set on December 31, 2021
How does NVS quarterly cash & cash equivalents rank versus sector peers?: NVS quarterly cash & cash equivalents is higher than 98.92% of companies in Healthcare sector
When is NVS next earnings release?: The next earnings release for NVS is on February 3, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

NVS Official Website www.novartis.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs